Cereno Scientific AB (publ) Share Price NORDIC GROWTH MARKET
Equities
CRNO B
SE0008241558
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.521 SEK | -7.13% | +7.98% | -76.90% |
05-02 | Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025 | CI |
04-16 | Cereno Scientific AB Approves Election of New Directors | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.03B 95.73M 7.54B |
---|---|---|---|---|---|
Net income 2024 * | -75M -7M -551M | Net income 2025 * | -42M -3.92M -309M | EV / Sales 2024 * | - |
Net Debt 2024 * | 3M 280K 22.05M | Net Debt 2025 * | 145M 13.55M 1.07B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18.8
x | P/E ratio 2025 * |
-21
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.66% |
1 day | -7.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 31/08/15 | |
Eva Jagenheim
DFI | Director of Finance/CFO | 58 | 27/08/23 |
Fredrik Frick
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/04/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 71 | 11/04/12 | |
Director/Board Member | 71 | - | |
Director/Board Member | 47 | 11/04/12 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- CRNO B Stock
- CRNO B Stock